How a new trial is testing a novel pill for blood glucose management – currently enrolling!
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
59 readers recommended
Twitter summary: FDA approves Novo Nordisk’s chronic weight management drug Saxenda, another option to help treat #obesity On December 23, the FDA approved Novo Nordisk’...
42 readers recommended
Complete with a savings card, a patient coaching program, and more!
43 readers recommended
How fast are insulin prices actually rising? Why might this be happening, and what is the impact on patients with varying levels of health care coverage?
44 readers recommended
Our deep dive on a new therapy now available in Europe – the benefits, risks, and when it might come to the US.
29 readers recommended
A clinical trial takes a new approach to type 1 prevention research.
49 readers recommended
The symptoms, who is at risk, and what every patient on SGLT-2 inhibitors can do right now.
51 readers recommended
What happens when these two unique drugs are taken together?
39 readers recommended
How a single change at the FDA could lead to major improvements for patients and the healthcare system.
38 readers recommended
Lilly announced that the FDA has approved its Humalog 200 units/mL KwikPen (insulin lispro) for type 1 and type 2 diabetes, making it the first concentrated mealtime...
46 readers recommended
Sanofi and MannKind announce Afrezza's official US launch.
38 readers recommended
How these two FDA-submitted drugs could address this major healthcare need.
27 readers recommended
Kicking off this weekend, what are we most excited about for this year’s ADA?
22 readers recommended
How a major research study is challenging an outdated FDA restriction.
50 readers recommended
What this dramatic movement in obesity therapy means for patients in Europe.
37 readers recommended
By Kelly Close Twitter Summary: @kellyclose speaks to @US_FDA in favor of PCSK9 inhibitor drug Praluent – need to bring more options to #PWD to fight against CV disease...
28 readers recommended
How this “disease interception” strategy could transform our knowledge of type 1 diabetes.
Harvard Stem Cell Lab Signs Two Major Partnerships to Bring Stem Cell Therapies for Diabetes to Life
33 readers recommended
Dr. Doug Melton and colleagues at the Harvard Stem Cell Institute recently announced new partnerships with Novartis and AstraZeneca to advance stem cell research for...
45 readers recommended
One of the biggest drug highlights at the 2015 ADA Scientific Sessions was a compelling presentation by diaTribe scientific Advisory Board member Dr. John Buse on brand...
51 readers recommended
First-ever SGLT-2/DPP-4 inhibitor drug, will this combination cut costs for patients?